Back to Search
Start Over
Two Trials of Therapeutics for MASH with Liver Fibrosis.
- Source :
-
The New England journal of medicine [N Engl J Med] 2024 Oct 17; Vol. 391 (15), pp. 1461. - Publication Year :
- 2024
- Subjects :
- Humans
Clinical Trials, Phase II as Topic
Weight Loss drug effects
Receptors, Gastrointestinal Hormone agonists
Receptors, Glucagon agonists
Liver Cirrhosis drug therapy
Liver Cirrhosis etiology
Liver Cirrhosis metabolism
Non-alcoholic Fatty Liver Disease complications
Non-alcoholic Fatty Liver Disease drug therapy
Non-alcoholic Fatty Liver Disease metabolism
Glucagon-Like Peptide-1 Receptor Agonists administration & dosage
Glucagon-Like Peptide-1 Receptor Agonists adverse effects
Gastric Inhibitory Polypeptide administration & dosage
Gastric Inhibitory Polypeptide adverse effects
Gastric Inhibitory Polypeptide analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1533-4406
- Volume :
- 391
- Issue :
- 15
- Database :
- MEDLINE
- Journal :
- The New England journal of medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39413385
- Full Text :
- https://doi.org/10.1056/NEJMc2411003